Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Integrated Analysis of Proteome and Transcriptome Profiling Reveals Pan-Cancer-Associated Pathways and Molecular Biomarkers

28 Jan 2025

Abstract excerpt

Understanding dysregulated genes and pathways in cancer is critical for precision oncology. Integrating mass spectrometry-based proteomic data with transcriptomic data presents unique opportunities for systematic analyses of dysregulated genes and pathways in pan-cancer. Here, we compiled a comprehensive set of datasets, encompassing proteomic data from 2404 samples and transcriptomic data from 7752 samples...

Source

Identifiers

PMID: 39884577
DOI: 10.1016/j.mcpro.2025.100919

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrated Analysis of Proteome and Transcriptome Profiling Reveals Pan-Cancer-Associated Pathways and Molecular BiomarkersPMID 39884577Read ↗

Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancersSemantic proximity Read ↗

Pan-cancer and multiomics: advanced strategies for diagnosis, prognosis, and therapy in the complex genetic and molecular universe of cancerSemantic proximity Read ↗

Development of Prognostic Signature Based on Pan-cancer ProteomicsSemantic proximity Read ↗

Cuproptosis-related gene DLAT is a prognostic and immunological biomarker in pan-cancerSemantic proximity Read ↗

An integrative and comparative study of pan-cancer transcriptomes reveals distinct cancer common and specific signatures.Semantic proximity Read ↗

The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targetsSemantic proximity Read ↗

Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathwaysSemantic proximity Read ↗

PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinomaSemantic proximity Read ↗

CancerProteome: a resource to functionally decipher the proteome landscape in cancerSemantic proximity Read ↗

A systems biology approach to unveil shared therapeutic targets and pathological pathways across major human cancersSemantic proximity Read ↗

A Systems Biology Approach to Unveil Shared Therapeutic Targets and Pathological Pathways Across Major Human CancersSemantic proximity Read ↗

UBE2C : A pan‐cancer diagnostic and prognostic biomarker revealed through bioinformatics analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.